PRIMARY STRUCTURE AND MOLECULAR-BASIS OF POLYMORPHIC APPEARANCE OF AN ACETYLTRANSFERASE (AT-II) IN HAMSTERS

被引:20
作者
NAGATA, K
OZAWA, S
MIYATA, M
SHIMADA, M
YAMAZOE, Y
KATO, R
机构
[1] Department of Pharmacology, School of Medicine, Keio University, Tokyo, 35 Shinanomachi
来源
PHARMACOGENETICS | 1994年 / 4卷 / 02期
关键词
D O I
10.1097/00008571-199404000-00006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Three hamster clones (clones 1, 2 and 3) were isolated from a genomic library constructed from a homozygote rapid acetylator using a cDNA (hamAT-101) of a monomorphic acetyltransferase (AT-I) as a probe. Clone 1 (13 kbp) was found to contain a gene corresponding to AT-I. The entire coding region was located in an exon and completely identical to that of AT-I cDNA. Clones 2 and 3 (14.5 and 15 kbp) each contained identical information to the AT-I-related protein (AT-B protein). The intronless coding region shared 83.7% of sequence similarly to the AT-I cDNA, and its length was identical to that of the AT-I cDNA. Clone 2 also included a nucleotide sequence identical to the 3'-portion of the AT-I gene, which is located 5'-upstream of the AT-B gene. Restricted fragment lengths of clone 3, which encompassed the entire coding region was expressed in COS-1 cells. The expressed protein migrated at a position identical to that of AT-II purified from a hamster liver on Western blots. AT-B-expressed protein catalysed acetyl CoA-dependent N-acetylation of 2-aminofluorene and p-aminobenzoic acid, but had marginal activities for O-acetylation of 2-N-hydroxyamino-6-methyl-6-methyldipyrido[,2-a:3',2'-d]imidazole and N-hydroxyarylacetamide-dependent N-acetylation of 4-aminoazobenzene. These results are in good agreement with the data of AT-II purified from hamster livers, indicating that the AT-B gene encodes a polymorphic acetyltransferase (AT-II) in hamsters. Although the AT-II protein was undetectable in slow acetylators, specific mRNA, hybridizing with a selective oligonucleotide probe for the AT-II gene (AT-B), was detected in livers of both homozygous acetylators. Analysis of genomic DNA of a homozygous slow phenotype hamster indicates that AT-II DNA from the slow phenotype has a point mutation which causes premature termination at the 243th (Arg to stop codon) position of the deduced amino acid sequence. PCR-RFLP analysis further confirmed that the point mutation conferred a defective AT-II protein in slow phenotype hamsters.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 31 条
[1]   AN ARYLAMINE ACETYLTRANSFERASE (AT-I) FROM SYRIAN GOLDEN-HAMSTER LIVER - CLONING, COMPLETE NUCLEOTIDE-SEQUENCE, AND EXPRESSION IN MAMMALIAN-CELLS [J].
ABUZEID, M ;
NAGATA, K ;
MIYATA, M ;
OZAWA, S ;
FUKUHARA, M ;
YAMAZOE, Y ;
KATO, R .
MOLECULAR CARCINOGENESIS, 1991, 4 (01) :81-88
[2]   NUCLEOTIDE-SEQUENCE OF RABBIT NAT2 ENCODING POLYMORPHIC LIVER ARYLAMINE N-ACETYLTRANSFERASE (NAT) [J].
BLUM, M ;
HEIM, M ;
MEYER, UA .
NUCLEIC ACIDS RESEARCH, 1990, 18 (17) :5295-5295
[3]   NUCLEOTIDE-SEQUENCE OF RABBIT NAT1 ENCODING MONOMORPHIC ARYLAMINE N-ACETYLTRANSFERASE [J].
BLUM, M ;
HEIM, M ;
MEYER, UA .
NUCLEIC ACIDS RESEARCH, 1990, 18 (17) :5287-5287
[4]   N-ACETYLATION PHARMACOGENETICS - A GENE DELETION CAUSES ABSENCE OF ARYLAMINE N-ACETYLTRANSFERASE IN LIVER OF SLOW ACETYLATOR RABBITS [J].
BLUM, M ;
GRANT, DM ;
DEMIERRE, A ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9554-9557
[5]   ACETYL TRANSFER IN ARYLAMINE METABOLISM [J].
BOOTH, J .
BIOCHEMICAL JOURNAL, 1966, 100 (03) :745-&
[6]  
CARTWRIGHT RA, 1982, LANCET, V2, P842
[7]   ELECTROPORATION FOR THE EFFICIENT TRANSFECTION OF MAMMALIAN-CELLS WITH DNA [J].
CHU, G ;
HAYAKAWA, H ;
BERG, P .
NUCLEIC ACIDS RESEARCH, 1987, 15 (03) :1311-1326
[8]  
FLAMMANG TJ, 1992, J PHARMACOL EXP THER, V260, P865
[9]   NUCLEOTIDE-SEQUENCE OF AN INTRONLESS GENE FOR A HUMAN ARYLAMINE N-ACETYLTRANSFERASE RELATED TO POLYMORPHIC DRUG ACETYLATION [J].
GRANT, DM ;
BLUM, M ;
DEMIERRE, A ;
MEYER, UA .
NUCLEIC ACIDS RESEARCH, 1989, 17 (10) :3978-3978
[10]  
HEIN DW, 1985, J PHARMACOL EXP THER, V233, P584